ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625541 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625541; 2) Community: the network communities that were significantly associated with the response to NSC 625541; 3) Molecule: the relationships between components within communities and NSC 625541; 4) MDR: the compounds that were significantly associated with the NSC 625541.

NSC Compound Enrichment Correlation
NSC 638388 Null 0.00423163567577548 0.26423088
NSC 639187 Landomycin A 0.00423163567577548 0.3919249
NSC 642049 Acetamide, N-(3-acetylphenyl)-2-[(4-amino-5-mercapto- 4H-1,2,4-triazol-3-yl)hydrazino]-2-oxo- 0.00423163567577548 0.30226577
NSC 648365 Insulin-Methotrexate conjugate 0.00423163567577548 0.057896615
NSC 670225 cis-2((1-(4-methyl-phenyl)methyl)-4-tert.butylcyclohexyl)oxyN,N-dimethyl-1-ethanamine-,salt with fumaric acid 0.00423163567577548 0.29035548
NSC 670404 Null 0.00423163567577548 0.24947344
NSC 672131 Null 0.00423163567577548 0.34173014
NSC 681541 Benzoic acid, 4-[[2-(1,4-dihydroxynaphthalenyl)methyl]amino]-, methyl ester 0.00423163567577548 0.24027544
NSC 684567 4,6(1H,5H)-Pyrimidinedione, 5-[3-[4-(diethylamino)phenyl]- 2-propenylidene]-2,3-dihydro-2-thioxo- 0.00423163567577548 0.26936343
NSC 696253 2-Propyn-1-one, 3-(2,4-dimethoxy-5-pyrimidinyl)-1-(3-methoxyphenyl)- 0.00423163567577548 0.12844704
Total:94  Current:12    [First] [Prev] [Next] [Last]